1 of 36

MRI for Diagnosis of MSK Tumors

Seul Ki Lee

Department of Radiology, St. Vincent’s Hospital, The Catholic University of Korea, South Korea

Qualitative and Quantitative Analysis for Tissue Composition

2 of 36

Imaging modalities for MSK tumors

3 of 36

Imaging modalities for MSK tumors

  • Plain radiographs and CT scans
    • Bone involvement

Multiple ill-defined osteolytic lesions in both centric and eccentric ways. WS Choi, SK Lee et al. J Korean Soc Radiol. 2023

Angiosarcoma of bone

• Mineralization

Stippled calcification in soft tissue opacity of distal femur.

EB Cho, SK Lee et al. Cancers 2023

Synovial sarcoma

4 of 36

Imaging modalities for MSK tumors

  • Ultrasound
    • Cystic vs. Solid

• Vascularity

Heterogeneously anechoic and echogenic mass; anechoic regions reflecting cystic/necrotic change.

EB Cho, SK Lee et al. Cancers 2023

Synovial sarcoma

Axial T2WI fat sup.

Axial enhanced T1WI fat sup.

Axial T1WI fat sup.

Coronal T2WI

Fig. 1A

B

C

D

C

Fig. 2A

“yin-yang” sign

Swirling color flow, a characteristic “yin-yang” sign within the mass. J Bae, SK Lee et al. Poster presentation @ KSUM 2023

Pseudoaneurysm

5 of 36

Workup of soft tissue mass

Surg Clin N Am 100 (2020) 669–680

Soft tissue mass

Small, slow-growing, mobile

Ultrasound

Solid, rapid growing, fixed, deep

MRI + contrast

Non-lipoma

Lipoma

MRI protocol

MRI + contrast

6 of 36

MRI protocols for MSK tumors

    • Conventional sequences: T1WI, T2WI, T2 fat suppression (fluid sensitive seq), T1 contrast enhancement + fat suppression

    • Axial & longitudinal - coronal (mediolateral) or sagittal (anteroposterior)
      • FOV? Small (resolution of tumor ↑) vs. Large (anatomic coverage ↑)

    • Advanced sequences (selective): diffusion-weighted image (DWI), dynamic contrast enhancement (DCE), IVIM, spectroscopy, DTI, etc…

6

7 of 36

Tissue composition on MRI scans

8 of 36

MRI – Tissue composition

T2

T2 fat suppression

+

T1

+contrast

No enhance

Lipoma

[Mature fat component] Absolute benign case

9 of 36

MRI – Tissue composition

T2

T2 fat suppression

+

T1

+contrast

No enhance

[Mature fat component] Absolute benign case

Intraosseous lipoma

10 of 36

MRI – Tissue composition

T2

T2 fat suppression

-

T1

+contrast

Rim enhance

[Pure fluid component] Absolute benign case

Ganglion cyst

11 of 36

MRI – Tissue composition

T2

T2 fat suppression

-

T1

+contrast

Rim enhance

[Pure fluid component] Absolute benign case

Intraosseous ganglion cyst

12 of 36

Absolute benign cases by Tissue composition

The MRI features are sufficiently specific to allow a histologic diagnosis in a small number of pathologic conditions. Most lesions are lack of sufficient specificity at MRI for enabling a diagnosis. (rec) biopsy

  • Lipoma: T2 high, T1 high, + fat suppression (+)

  • Cyst: T2 high, T1 low (variable) + fat supp (-) + thin rim enhance

13 of 36

MRI – Tissue composition

  • Lipoma vs. hematoma?

T1 and T2 both high SI

No enhancement

Fat suppression (using water and fat only)

Atypical lipomatous tumor

T1 T2 +CE

Dixon water fat

T1 T2 +CE

Dixon water fat

Hematoma

Fat suppression (using water and fat only)

14 of 36

T1 hyperintense mimicker, hematoma

  • SI characteristics of hematoma on MRI

  • Confirm presence or absence of enhancement by post-contrast subtraction image or non-contrast T1 fat suppression image.

T1 T2 T1 Water +CE

hematoma

15 of 36

MRI – Tissue composition

  • When shouldn’t I call it a cyst?

+

T2 high SI

Thin wall enhancement

T2 shine through effect

T2 T2 water T1 +CE

b50 b800 ADC

T2 shine through effect

Neurogenic tumor

(myxoid tumor)

heterogeneously

16 of 36

MRI – Tissue composition

  • When shouldn’t I call it a cyst?

Homogeneously T2 high SI

wall enhancement

T2 shine through effect

T2 shine through effect

Myxoma

T2 T2 water T1 +CE

b50 b800 ADC

irregular

17 of 36

MRI – Tissue composition

  • When shouldn’t I call it a cyst?

T2 high SI

wall enhancement

T2 shine through effect

T2 shine through effect

Metastatic lymph node with necrotic change

nodular

T2 T2 water T1 +CE

b50 b800 ADC

18 of 36

T2 hyperintense mimicker, pseudocystic

  • Myxoid tumors:
    • T2WI: near-fluid SI
    • Thin septal enhancement & heterogeneity on T1 and T2WI
    • Ganglion cyst: periarticular area (synovial line, bursa, joint recess, fibrocartilages, periosteal, traumatic, surgical seroma..)

  • Necrotic change of malignant solid tumors:
    • T2WI: near-fluid SI
    • Thick and nodular enhancement & heterogeneity on T1 and T2WI
    • Perilesional edema

  • Synovial sarcoma, vascular tumor, chondroid tumor

Myxoma, neurogenic tumor, myxoid sarcoma (myxoid liposarcoma, myxoid fibrosarcoma)

+DWI

19 of 36

Any mass with non-specific MRI features

20 of 36

Any mass with non-specific MRI features

  • Iso T1 and heterogeneously high T2: non-specific MRI appearance

🡪 referral to specialized tertiary care center

  • Narrowing the differential diagnosis!
    • Specific location: scapular elastofibroma dorsi, plantar fibroma, subungal glomus tumor, intermetatarsal Morton’s neuroma, Achilles xanthoma, abdominal wall desmoid tumor, neurogenic tumor, dermatofibrosarcoma protuberans, etc..
    • Many signs: neurogenic tumor (target sign, fascicular sign, entering/exiting nerve sign), myxoma (bright cap sign), myositis ossificans (zonal phenomenon), synovial sarcoma (triple sign, bowl of grapes), myxofibrosarcoma (tail sign), etc..
    • Containing T1, T2 low SI foci: tenosynovial giant cell tumor (d/t hemosiderin), fibrous tumor (fibromatosis, elastofibroma, fibrosarcoma), chondroid/osteoid tumor, crystal deposition disease, etc..

21 of 36

Any mass with non-specific MRI features

  • Iso T1 and high T2: non-specific MRI appearance

🡪 referral to specialized tertiary care center

  • Findings with increased risk of malignancy
    • Depth: deep to the fascia
    • Size: > 5 cm
    • Location: proximal lower extremity, retroperitoneum
    • T1: signal heterogeneity
    • T2: signal heterogeneity
    • Post-contrast T1: heterogeneous enhancement or necrotic change
    • Margin: ill-defined
    • Peritumoral edema: presence
    • DWI: diffusion restriction in solid mass (low ADC <1.1x10-3mm2/sec)
    • DCE: malignant perfusion pattern with early arterial enhancement

22 of 36

Biopsy

  • Indications: any mass for which imaging is no definitive
  • Equipment depends on target lesion

Soft tissue: side-cutting needle

Radiol Clin North Am 2008 Gogna

Cortical bone: not usually a target, use a drill to penetrate

(most painful, not for bx)

Cancellous bone: can be hard if sclerotic or soft if destroyed

23 of 36

Biopsy

  • Planning the biopsy
    • Biopsy track to be included in surgical specimen
    • Biopsy should not violate more than on compartment
    • Biopsy the soft tissue component of a bone lesion if present

  • Imaging guided-biopsy
    • Avoid vital structures
    • Select the most appropriate part of the lesion
      • Target location with highest yield
    • Select a path that will be excised along with the tumor
    • Avoid contaminating compartments
    • Beware of bloody lesions: RCC, osteosarcoma, hemangioma

24 of 36

Advanced role of functional MRI for MSK tumors

25 of 36

Dixon technique (phase-contrast tech.)

25

    • Difference in resonance frequencies 🡪 change of phases of lipid protons and water protons after the initial excitation
    • Both in-phase and opposed-phase images are acquired with a spin-echo sequence: Water only = (SIP + SOP)/2, Fat only = (SIP – SOP)/2

Advantages:

  • (3-point) Lesser sensitive to B1 and B0 heterogeneity than fat saturation 🡪 homogenous fat suppression (metallic implant, head/neck, or lung apices)
  • Higher SNR than STIR
  • Added to T1WI (enhanced), T2WI, and PDWI
  • A single-image acquisition, w/ and w/o fat suppression
  • Fat quantification

Dixon method Questions and Answers in MRI

26 of 36

Dixon and MSK tumor

  • Quantification of fat
    • Zajick et al.: a 20% decrease in SI on the opposed-phase images relatively to that on the in-phase imaging
      • Spine bone marrow lesion or compression fracture; true marrow-replacing tumor vs. infiltrative process such as edema, red marrow hyperplasia..
      • Opposed-phase에서 SI drop이 있는 경우는 fat이 존재하는 것으로 benign에 가깝다.

  • Fat fraction values were calculated with the following formula:
    • % signal drop = (SI IP – SI OP ) / 2SI IP × 100

27 of 36

Marrow lesion

(metastasis vs. felon)

In phase

Opposed phase

malignant

benign

Mean 679.5 Mean 854.1

T2 FS

T1 in

T1 out

Breast cancer bone metastasis

T2 FS

T1 in

T1 out

Mean 975.5 Mean 135.9

Animal bite OM

28 of 36

Diffusion-weighted image

  • Quantification of cellularity
    • Signal losses on DWI are proportional to both the free motion of water molecules and the diffusion gradient strength.
      • When diffusion is high, the return to phase is incomplete and spins are out of phase.
      • In hypercellular lesions, diffusion is restricted, the spins are poorly mobile and return to phase.
    • DWI should be assessed visually, comparing between a low b-value image and a high b-value image.
    • The difference in signal between these two images is related to water diffusion, often termed the ADC.

KCR 2020

29 of 36

DWI and MSK lesions

Y Kim, SK Lee et al. Diagnostics 2023

epidermal inclusion cyst

In tumorous conditions, DWI typically shows low ADC values in malignant aggressive tumors, while benign tumors usually exhibit high ADC values.

* DWI has also been shown to be effective in detecting abscesses containing protein-rich, epidermal inclusion cyst containing viscous liquid as restricted diffusion

Diffusion restriction

30 of 36

DWI: quantification of cellularity + heterogeneity

31 of 36

Dynamic contrast-enhanced MRI

  • Malignant lesion:
    • incomplete vascular endothelial cells and high vascular permeability 🡪 increase the leakage of contrast agent

    • hypervascularity with frequently associated with microscopic necrotic change 🡪 weaken the power of Ve

    • Compounding effect of Ktrans and Ve may be the main reason for better correlation between quantitative parameter of Kep & histology of microvessel density

    • iAUC: combined influence of blood volume, flow, and permeability, but is likely dominated by blood volume

Ktrans

Ve

Kep =

Ktrans, volume transfer contast (permeability);

Ve, extracellular space per unit volume of tissue;

Kep, rate constant (ratio of Ktrans and Ve)

SK Lee et al. Oral presentation @ RSNA 2018

32 of 36

Initial

DCE-MRI

Time intensity curve

FU 3 months

KCR 2017

33 of 36

DCE: Quantification of perfusion

34 of 36

Conclusion

35 of 36

Conclusion

  • MSK tumors are a complex and heterogeneous group of tumors.

    • Narrowing the differential diagnosis by tissue composition

    • Addition of functional sequences to the conventional MRI protocols increases the diagnostic accuracy of interpretations for MSK tumors

36 of 36

Thank You

36